BNP Paribas Exane Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX) had its target price decreased by equities research analysts at BNP Paribas Exane from $128.00 to $97.00 in a research report issued to clients and investors on Tuesday,MarketScreener reports. The brokerage presently has a “neutral” rating on the stock. BNP Paribas Exane’s price objective points to a potential upside of 9.00% from the company’s previous close.

CLX has been the subject of several other research reports. Morgan Stanley lowered their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. Weiss Ratings upgraded shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, April 13th. Barclays dropped their target price on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. TD Cowen increased their price target on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a report on Tuesday, March 31st. Finally, JPMorgan Chase & Co. reduced their price target on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat, Clorox presently has an average rating of “Reduce” and an average target price of $103.73.

Clorox Stock Performance

Clorox stock opened at $88.99 on Tuesday. Clorox has a twelve month low of $84.70 and a twelve month high of $138.03. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The company has a market capitalization of $10.76 billion, a P/E ratio of 14.42, a PEG ratio of 0.48 and a beta of 0.59. The stock’s 50 day moving average is $104.59 and its 200 day moving average is $107.63.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the business earned $1.45 earnings per share. The firm’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts predict that Clorox will post 5.63 earnings per share for the current fiscal year.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.63% of the company’s stock.

Institutional Trading of Clorox

Several large investors have recently added to or reduced their stakes in CLX. Center for Financial Planning Inc. bought a new stake in Clorox during the third quarter valued at about $25,000. Vermillion & White Wealth Management Group LLC purchased a new position in shares of Clorox during the 3rd quarter valued at about $25,000. Caitlin John LLC grew its stake in shares of Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after acquiring an additional 253 shares during the period. Root Financial Partners LLC bought a new position in shares of Clorox during the 3rd quarter valued at approximately $29,000. Finally, Darwin Wealth Management LLC purchased a new stake in Clorox in the 2nd quarter worth approximately $29,000. 78.53% of the stock is currently owned by institutional investors.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.